Liver lesion detection and characterization: Role of diffusion-weighted imaging

Journal of Magnetic Resonance Imaging

Volumn 37, Issue 6, 2013, Pages 1260-1276

  Galea, Nicola ^a,b   Cantisani, Vito ^a   Taouli, Bachir ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

diffusion; echo planar imaging; hemangioma; hepatocellular carcinoma; liver lesions; metastases

Indexed keywords

GADOLINIUM; GADOXETIC ACID; MANGAFODIPIR; SUPERPARAMAGNETIC IRON OXIDE;

ARTIFACT; BREATHING; COMPARATIVE STUDY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; ECHO PLANAR IMAGING; HEPATOGRAPHY; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; LIVER CELL CARCINOMA; LIVER HEMANGIOMA; LIVER INJURY; LIVER METASTASIS; LIVER PARENCHYMA; PRIORITY JOURNAL; QUALITATIVE DIAGNOSIS; QUANTITATIVE DIAGNOSIS; RECEIVER OPERATING CHARACTERISTIC; REVIEW; SENSITIVITY AND SPECIFICITY;

ALGORITHMS; DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LIVER; LIVER NEOPLASMS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84878221137     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.23947     Document Type: Review

References (119)

1. Rofsky NM, Lee VS, Laub G, et al. Abdominal MR imaging with a volumetric interpolated breath-hold examination. Radiology 1999; 212: 876-884.
2. Lee VS, Lavelle MT, Krinsky GA, Rofsky NM,. Volumetric MR imaging of the liver and applications. Magn Reson Imaging Clin N Am 2001; 9: 697-716, v-vi.
3. Semelka RC, Martin DR, Balci C, Lance T,. Focal liver lesions: comparison of dual-phase CT and multisequence multiplanar MR imaging including dynamic gadolinium enhancement. J Magn Reson Imaging 2001; 13: 397-401.
4. Braga L, Guller U, Semelka RC,. Modern hepatic imaging. Surg Clin North Am 2004; 84: 375-400.
5. Danrad R, Martin DR,. MR imaging of diffuse liver diseases. Magn Reson Imaging Clin N Am 2005; 13: 277-293, vi.
6. Low RN,. Abdominal MRI advances in the detection of liver tumours and characterisation. Lancet Oncol 2007; 8: 525-535.
7. Delannoy J, Chen CN, Turner R, Levin RL, Le Bihan D,. Noninvasive temperature imaging using diffusion MRI. Magn Reson Med 1991; 19: 333-339.
8. Luypaert R, Boujraf S, Sourbron S, Osteaux M,. Diffusion and perfusion MRI: basic physics. Eur J Radiol 2001; 38: 19-27.
9. Bammer R,. Basic principles of diffusion-weighted imaging. Eur J Radiol 2003; 45: 169-184.
10. Nicholson C, Phillips JM,. Ion diffusion modified by tortuosity and volume fraction in the extracellular microenvironment of the rat cerebellum. J Physiol 1981; 321: 225-257.
11. Taouli B, Koh DM,. Diffusion-weighted MR imaging of the liver. Radiology 2010; 254: 47-66.
12. Taouli B, Vilgrain V, Dumont E, Daire JL, Fan B, Menu Y,. Evaluation of liver diffusion isotropy and characterization of focal hepatic lesions with two single-shot echo-planar MR imaging sequences: prospective study in 66 patients. Radiology 2003; 226: 71-78.
13. Koh DM, Padhani AR,. Diffusion-weighted MRI: a new functional clinical technique for tumour imaging. Br J Radiol 2006; 79: 633-635.
14. Papanikolaou N, Gourtsoyianni S, Yarmenitis S, Maris T, Gourtsoyiannis N,. Comparison between two-point and four-point methods for quantification of apparent diffusion coefficient of normal liver parenchyma and focal lesions. Value of normalization with spleen. Eur J Radiol 2010; 73: 305-309.
15. Le Bihan D, Breton E, Lallemand D, Aubin ML, Vignaud J, Laval-Jeantet M,. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 1988; 168: 497-505.
16. Dixon WT,. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging: a modest proposal with tremendous potential. Radiology 1988; 168: 566-567.
17. Le Bihan D, Turner R, Douek P, Patronas N,. Diffusion MR imaging: clinical applications. AJR Am J Roentgenol 1992; 159: 591-599.
18. Patel J, Sigmund EE, Rusinek H, Oei M, Babb JS, Taouli B,. Diagnosis of cirrhosis with intravoxel incoherent motion diffusion MRI and dynamic contrast-enhanced MRI alone and in combination: preliminary experience. J Magn Reson Imaging 2010; 31: 589-600.
19. Koh DM, Collins DJ,. Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol 2007; 188: 1622-1635.
20. Chandarana H, Taouli B,. Diffusion and perfusion imaging of the liver. Eur J Radiol 2010; 76: 348-358.
21. Butts K, Riederer SJ, Ehman RL, Felmlee JP, Grimm RC,. Echo-planar imaging of the liver with a standard MR imaging system. Radiology 1993; 189: 259-264.
22. Okada Y, Ohtomo K, Kiryu S, Sasaki Y,. Breath-hold T2-weighted MRI of hepatic tumors: value of echo planar imaging with diffusion-sensitizing gradient. J Comput Assist Tomogr 1998; 22: 364-371.
23. Namimoto T, Yamashita Y, Sumi S, Tang Y, Takahashi M,. Focal liver masses: characterization with diffusion-weighted echo-planar MR imaging. Radiology 1997; 204: 739-744.
24. Kwee TC, Takahara T, Koh DM, Nievelstein RA, Luijten PR,. Comparison and reproducibility of ADC measurements in breathhold, respiratory triggered, and free-breathing diffusion-weighted MR imaging of the liver. J Magn Reson Imaging 2008; 28: 1141-1148.
25. Taouli B, Sandberg A, Stemmer A, et al. Diffusion-weighted imaging of the liver: comparison of navigator triggered and breathhold acquisitions. J Magn Reson Imaging 2009; 30: 561-568.
26. Parikh T, Drew SJ, Lee VS, et al. Focal liver lesion detection and characterization with diffusion-weighted MR imaging: comparison with standard breath-hold T2-weighted imaging. Radiology 2008; 246: 812-822.
27. Kandpal H, Sharma R, Madhusudhan KS, Kapoor KS,. Respiratory-triggered versus breath-hold diffusion-weighted MRI of liver lesions: comparison of image quality and apparent diffusion coefficient values. AJR Am J Roentgenol 2009; 192: 915-922.
28. Dietrich O, Heiland S, Sartor K,. Noise correction for the exact determination of apparent diffusion coefficients at low SNR. Magn Reson Med 2001; 45: 448-453.
29. Kim SY, Lee SS, Byun JH, et al. Malignant hepatic tumors: short-term reproducibility of apparent diffusion coefficients with breath-hold and respiratory-triggered diffusion-weighted MR imaging. Radiology 2010; 255: 815-823.
30. Nasu K, Kuroki Y, Sekiguchi R, Nawano S,. The effect of simultaneous use of respiratory triggering in diffusion-weighted imaging of the liver. Magn Reson Med Sci 2006; 5: 129-136.
31. Nasu K, Kuroki Y, Fujii H, Minami M,. Hepatic pseudo-anisotropy: a specific artifact in hepatic diffusion-weighted images obtained with respiratory triggering. Magma 2007; 20: 205-211.
32. Murtz P, Flacke S, Traber F, van den Brink JS, Gieseke J, Schild HH,. Abdomen: diffusion-weighted MR imaging with pulse-triggered single-shot sequences. Radiology 2002; 224: 258-264.
33. de Bazelaire CM, Duhamel GD, Rofsky NM, Alsop DC,. MR imaging relaxation times of abdominal and pelvic tissues measured in vivo at 3.0 T: preliminary results. Radiology 2004; 230: 652-659.
34. Stanisz GJ, Odrobina EE, Pun J, et al. T1, T2 relaxation and magnetization transfer in tissue at 3T. Magn Reson Med 2005; 54: 507-512.
35. van den Bos IC, Hussain SM, Krestin GP, Wielopolski PA,. Liver imaging at 3.0 T: diffusion-induced black-blood echo-planar imaging with large anatomic volumetric coverage as an alternative for specific absorption rate-intensive echo-train spin-echo sequences: feasibility study. Radiology 2008; 248: 264-271.
36. Braithwaite AC, Dale BM, Boll DT, Merkle EM,. Short- and midterm reproducibility of apparent diffusion coefficient measurements at 3.0-T diffusion-weighted imaging of the abdomen. Radiology 2009; 250: 459-465.
37. Rosenkrantz AB, Oei M, Babb JS, Niver BE, Taouli B,. Diffusion-weighted imaging of the abdomen at 3.0 Tesla: image quality and apparent diffusion coefficient reproducibility compared with 1.5 Tesla. J Magn Reson Imaging 2011; 33: 128-135.
38. Moteki T, Sekine T,. Echo planar MR imaging of the liver: comparison of images with and without motion probing gradients. J Magn Reson Imaging 2004; 19: 82-90.
39. Nasu K, Kuroki Y, Nawano S, et al. Hepatic metastases: diffusion-weighted sensitivity-encoding versus SPIO-enhanced MR imaging. Radiology 2006; 239: 122-130.
40. Coenegrachts K, Delanote J, Ter Beek L, et al. Improved focal liver lesion detection: comparison of single-shot diffusion-weighted echoplanar and single-shot T2 weighted turbo spin echo techniques. Br J Radiol 2007; 80: 524-531.
41. Koh DM, Brown G, Riddell AM, et al. Detection of colorectal hepatic metastases using MnDPDP MR imaging and diffusion-weighted imaging (DWI) alone and in combination. Eur Radiol 2008; 18: 903-910.
42. Bruegel M, Gaa J, Waldt S, et al. Diagnosis of hepatic metastasis: comparison of respiration-triggered diffusion-weighted echo-planar MRI and five t2-weighted turbo spin-echo sequences. AJR Am J Roentgenol 2008; 191: 1421-1429.
43. Zech CJ, Herrmann KA, Dietrich O, Horger W, Reiser MF, Schoenberg SO,. Black-blood diffusion-weighted EPI acquisition of the liver with parallel imaging: comparison with a standard T2-weighted sequence for detection of focal liver lesions. Invest Radiol 2008; 43: 261-266.
44. Wang H, Wang X-Y, Jiang X-X, Ye Z-X,. Comparison of diffusion-weighted with T2-weighted imaging for detection of small hepatocellular carcinoma in cirrhosis preliminary quantitative study at 3-T. Acad Radiol 2010; 17: 239-243.
45. Hussain SM, De Becker J, Hop WC, Dwarkasing S, Wielopolski PA,. Can a single-shot black-blood T2-weighted spin-echo echo-planar imaging sequence with sensitivity encoding replace the respiratory-triggered turbo spin-echo sequence for the liver? An optimization and feasibility study. J Magn Reson Imaging 2005; 21: 219-229.
46. Kim T, Murakami T, Takahashi S, Hori M, Tsuda K, Nakamura H,. Diffusion-weighted single-shot echoplanar MR imaging for liver disease. AJR Am J Roentgenol 1999; 173: 393-398.
47. Cui X-Y,. Role of diffusion-weighted magnetic resonance imaging in the diagnosis of extrahepatic cholangiocarcinoma. World J Gastroenterol 2010; 16: 3196.
48. Hardie AD, Naik M, Hecht EM, et al. Diagnosis of liver metastases: value of diffusion-weighted MRI compared with gadolinium-enhanced MRI. Eur Radiol 2010; 20: 1431-1441.
49. Soyer P, Boudiaf M, Place V, et al. Preoperative detection of hepatic metastases: comparison of diffusion-weighted, T2-weighted fast spin echo and gadolinium-enhanced MR imaging using surgical and histopathologic findings as standard of reference. Eur J Radiol 2011; 80: 245-252.
50. Low RN, Gurney J,. Diffusion-weighted MRI (DWI) in the oncology patient: value of breathhold DWI compared to unenhanced and gadolinium-enhanced MRI. J Magn Reson Imaging 2007; 25: 848-858.
51. Kenis C, Deckers F, De Foer B, Van Mieghem F, Van Laere S, Pouillon M,. Diagnosis of liver metastases: can diffusion-weighted imaging (DWI) be used as a stand alone sequence? Eur J Radiol 2012; 81: 1016-1023.
52. Xu PJ, Yan FH, Wang JH, Lin J, Ji Y,. Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis. J Magn Reson Imaging 2009; 29: 341-349.
53. Vandecaveye V, De Keyzer F, Verslype C, et al. Diffusion-weighted MRI provides additional value to conventional dynamic contrast-enhanced MRI for detection of hepatocellular carcinoma. Eur Radiol 2009; 19: 2456-2466.
54. Muhi A, Ichikawa T, Motosugi U, et al. High-b-value diffusion-weighted MR imaging of hepatocellular lesions: estimation of grade of malignancy of hepatocellular carcinoma. J Magn Reson Imaging 2009; 30: 1005-1011.
55. Nasu K, Kuroki Y, Tsukamoto T, Nakajima H, Mori K, Minami M,. Diffusion-weighted imaging of surgically resected hepatocellular carcinoma: imaging characteristics and relationship among signal intensity, apparent diffusion coefficient, and histopathologic grade. AJR Am J Roentgenol 2009; 193: 438-444.
56. Nishie A, Tajima T, Ishigami K, et al. Detection of hepatocellular carcinoma (HCC) using super paramagnetic iron oxide (SPIO)-enhanced MRI: added value of diffusion-weighted imaging (DWI). J Magn Reson Imaging 2010; 31: 373-382.
57. Piana G, Trinquart L, Meskine N, Barrau V, Beers BV, Vilgrain V,. New MR imaging criteria with a diffusion-weighted sequence for the diagnosis of hepatocellular carcinoma in chronic liver diseases. J Hepatol 2011; 55: 126-132.
58. Hardie AD, Kizziah MK, Boulter DJ,. Diagnostic accuracy of diffusion-weighted MRI for identifying hepatocellular carcinoma with liver explant correlation. J Med Imaging Radiat Oncol 2011; 55: 362-367.
59. Furuhata T, Okita K, Tsuruma T, et al. Efficacy of SPIO-MR imaging in the diagnosis of liver metastases from colorectal carcinomas. Dig Surg 2003; 20: 321-325.
60. Vogl TJ, Schwarz W, Blume S, et al. Preoperative evaluation of malignant liver tumors: comparison of unenhanced and SPIO (Resovist)-enhanced MR imaging with biphasic CTAP and intraoperative US. Eur Radiol 2003; 13: 262-272.
61. Ward J, Robinson PJ, Guthrie JA, et al. Liver metastases in candidates for hepatic resection: comparison of helical CT and gadolinium- and SPIO-enhanced MR imaging. Radiology 2005; 237: 170-180.
62. Shimada K, Isoda H, Hirokawa Y, Arizono S, Shibata T, Togashi K,. Comparison of gadolinium-EOB-DTPA-enhanced and diffusion-weighted liver MRI for detection of small hepatic metastases. Eur Radiol 2010; 20: 2690-2698.
63. Lowenthal D, Zeile M, Lim WY, et al. Detection and characterisation of focal liver lesions in colorectal carcinoma patients: comparison of diffusion-weighted and Gd-EOB-DTPA enhanced MR imaging. Eur Radiol 2011; 21: 832-840.
64. Coenegrachts K, Matos C, Ter Beek L, et al. Focal liver lesion detection and characterization: comparison of non-contrast enhanced and SPIO-enhanced diffusion-weighted single-shot spin echo echo planar and turbo spin echo T2-weighted imaging. Eur J Radiol 2008; 10: 10.
65. Naganawa S, Sato C, Nakamura T, et al. Diffusion-weighted images of the liver: comparison of tumor detection before and after contrast enhancement with superparamagnetic iron oxide. J Magn Reson Imaging 2005; 21: 836-840.
66. Kiryu S, Watanabe M, Kabasawa H, Akahane M, Aoki S, Ohtomo K,. Evaluation of super paramagnetic iron oxide-enhanced diffusion-weighted PROPELLER T2-fast spin echo magnetic resonance imaging: preliminary experience. J Comput Assist Tomogr 2006; 30: 197-200.
67. Mori K, Takahashi N, Hiratsuka M, et al. Detection of hepatic metastases using ferucarbotran-enhanced MR imaging: feasibility and diagnostic accuracy of three-dimensional sensitivity-encoding water-excitation multishot echo-planar sequence (3D-SWEEP). J Magn Reson Imaging 2006; 24: 1110-1116.
68. Hammerstingl R, Huppertz A, Breuer J, et al. Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions. Eur Radiol 2008; 18: 457-467.
69. Ringe KI, Husarik DB, Sirlin CB, Merkle EM,. Gadoxetate disodium-enhanced MRI of the liver: part 1. Protocol optimization and lesion appearance in the noncirrhotic liver. AJR Am J Roentgenol 2010; 195: 13-28.
70. Cruite I, Schroeder M, Merkle EM, Sirlin CB,. Gadoxetate disodium-enhanced MRI of the liver: part 2. Protocol optimization and lesion appearance in the cirrhotic liver. AJR Am J Roentgenol 2010; 195: 29-41.
71. Tanimoto A, Lee JM, Murakami T, Huppertz A, Kudo M, Grazioli L,. Consensus report of the 2nd International Forum for Liver MRI. Eur Radiol 2009;(Suppl 5): S975-S989.
72. Choi JS, Kim MJ, Choi JY, Park MS, Lim JS, Kim KW,. Diffusion-weighted MR imaging of liver on 3.0-Tesla system: effect of intravenous administration of gadoxetic acid disodium. Eur Radiol 2010; 20: 1052-1060.
73. Saito K, Araki Y, Park J, et al. Effect of Gd-EOB-DTPA on T2-weighted and diffusion-weighted images for the diagnosis of hepatocellular carcinoma. J Magn Reson Imaging 2010; 32: 229-234.
74. Wang CL, Chea YW, Boll DT, et al. Effect of gadolinium chelate contrast agents on diffusion weighted MR imaging of the liver, spleen, pancreas and kidney at 3 T. Eur J Radiol 2011; 80: s1-e7.
75. Choi SA, Lee SS, Jung IH, Kim HA, Byun JH, Lee MG,. The effect of gadoxetic acid enhancement on lesion detection and characterisation using T2 weighted imaging and diffusion weighted imaging of the liver. Br J Radiol 2012; 85: 29-36.
76. Eiber M, Fingerle AA, Brugel M, Gaa J, Rummeny EJ, Holzapfel K,. Detection and classification of focal liver lesions in patients with colorectal cancer: retrospective comparison of diffusion-weighted MR imaging and multi-slice CT. Eur J Radiol 2012; 81: 683-691.
77. Inan N, Arslan A, Akansel G, et al. Diffusion-weighted imaging in the differential diagnosis of simple and hydatid cysts of the liver. AJR Am J Roentgenol 2007; 189: 1031-1036.
78. Holzapfel K, Bruegel M, Eiber M, et al. Characterization of small (
79. Ichikawa T, Haradome H, Hachiya J, Nitatori T, Araki T,. Diffusion-weighted MR imaging with a single-shot echoplanar sequence: detection and characterization of focal hepatic lesions. AJR Am J Roentgenol 1998; 170: 397-402.
80. Chandarana H, Taouli B,. Diffusion-weighted MRI and liver metastases. Magn Reson Imaging Clin N Am 2010; 18: 451-464.
81. Gudbjartsson H, Patz S,. The Rician distribution of noisy MRI data. Magn Reson Med 1995; 34: 910-914.
82. Yamada I, Aung W, Himeno Y, Nakagawa T, Shibuya H,. Diffusion coefficients in abdominal organs and hepatic lesions: evaluation with intravoxel incoherent motion echo-planar MR imaging. Radiology 1999; 210: 617-623.
83. Bruegel M, Holzapfel K, Gaa J, et al. Characterization of focal liver lesions by ADC measurements using a respiratory triggered diffusion-weighted single-shot echo-planar MR imaging technique. Eur Radiol 2008; 18: 477-485.
84. Gourtsoyianni S, Papanikolaou N, Yarmenitis S, Maris T, Karantanas A, Gourtsoyiannis N,. Respiratory gated diffusion-weighted imaging of the liver: value of apparent diffusion coefficient measurements in the differentiation between most commonly encountered benign and malignant focal liver lesions. Eur Radiol 2008; 18: 486-492.
85. Sandrasegaran K, Akisik FM, Lin C, Tahir B, Rajan J, Aisen AM,. The value of diffusion-weighted imaging in characterizing focal liver masses. Acad Radiol 2009; 16: 1208-1214.
86. Vossen JA, Buijs M, Liapi E, Eng J, Bluemke DA, Kamel IR,. Receiver operating characteristic analysis of diffusion-weighted magnetic resonance imaging in differentiating hepatic hemangioma from other hypervascular liver lesions. J Comput Assist Tomogr 2008; 32: 750-756.
87. Miller FH, Hammond N, Siddiqi AJ, et al. Utility of diffusion-weighted MRI in distinguishing benign and malignant hepatic lesions. J Magn Reson Imaging 2010; 32: 138-147.
88. Soyer P, Corno L, Boudiaf M, et al. Differentiation between cavernous hemangiomas and untreated malignant neoplasms of the liver with free-breathing diffusion-weighted MR imaging: comparison with T2-weighted fast spin-echo MR imaging. Eur J Radiol 2011; 80: 316-324.
89. Kilickesmez O, Bayramoglu S, Inci E, Cimilli T,. Value of apparent diffusion coefficient measurement for discrimination of focal benign and malignant hepatic masses. J Med Imaging Radiat Oncol 2009; 53: 50-55.
90. Erturk SM, Ichikawa T, Sano K, Motosugi U, Sou H, Araki T,. Diffusion-weighted magnetic resonance imaging for characterization of focal liver masses: impact of parallel imaging (SENSE) and b value. J Comput Assist Tomogr 2008; 32: 865-871.
91. Bruegel M, Holzapfel K, Gaa J, et al. Characterization of focal liver lesions by ADC measurements using a respiratory triggered diffusion-weighted single-shot echo-planar MR imaging technique. Eur Radiol 2007; 18: 477-485.
92. Chan JH, Tsui EY, Luk SH, et al. Diffusion-weighted MR imaging of the liver: distinguishing hepatic abscess from cystic or necrotic tumor. Abdom Imaging 2001; 26: 161-165.
93. Holzapfel K, Rummeny E, Gaa J,. Diffusion-weighted MR imaging of hepatic abscesses: possibility of different apparent diffusion coefficient (ADC)-values in early and mature abscess formation. Abdom Imaging 2007; 32: 538-539.
94. Charles-Edwards EM, deSouza NM,. Diffusion-weighted magnetic resonance imaging and its application to cancer. Cancer Imaging 2006; 6: 135-143.
95. Mannelli L, Kim S, Hajdu CH, Babb JS, Clark TW, Taouli B,. Assessment of tumor necrosis of hepatocellular carcinoma after chemoembolization: diffusion-weighted and contrast-enhanced MRI with histopathologic correlation of the explanted liver. AJR Am J Roentgenol 2009; 193: 1044-1052.
96. Nishie A, Tajima T, Asayama Y, et al. Diagnostic performance of apparent diffusion coefficient for predicting histological grade of hepatocellular carcinoma. Eur J Radiol 2011; 80: e29-e33.
97. Luciani A, Vignaud A, Cavet M, et al. Liver cirrhosis: intravoxel incoherent motion MR imaging-pilot study. Radiology 2008; 249: 891-899.
98. Xu PJ, Yan FH, Wang JH, Shan Y, Ji Y, Chen CZ,. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver. J Comput Assist Tomogr 2010; 34: 506-512.
99. Sun XJ, Quan XY, Huang FH, Xu YK,. Quantitative evaluation of diffusion-weighted magnetic resonance imaging of focal hepatic lesions. World J Gastroenterol 2005; 11: 6535-6537.
100. Yoshikawa T, Kawamitsu H, Mitchell DG, et al. ADC measurement of abdominal organs and lesions using parallel imaging technique. AJR Am J Roentgenol 2006; 187: 1521-1530.
101. Do RK, Chandanara H, Felker E, et al. Diagnosis of liver fibrosis and cirrhosis with diffusion-weighted imaging: value of normalized apparent diffusion coefficient using the spleen as reference organ. AJR Am J Roentgenol 2010; 195: 671-676.
102. Xia D, Jing J, Shen H, Wu J,. Value of diffusion-weighted magnetic resonance images for discrimination of focal benign and malignant hepatic lesions: a meta-analysis. J Magn Reson Imaging 2010; 32: 130-137.
103. Bruegel M, Rummeny EJ,. Hepatic metastases: use of diffusion-weighted echo-planar imaging. Abdom Imaging 2010; 35: 454-461.
104. Bammer R, Keeling SL, Augustin M, et al. Improved diffusion-weighted single-shot echo-planar imaging (EPI) in stroke using sensitivity encoding (SENSE). Magn Reson Med 2001; 46: 548-554.
105. Bammer R, Auer M, Keeling SL, et al. Diffusion tensor imaging using single-shot SENSE-EPI. Magn Reson Med 2002; 48: 128-136.
106. Taouli B, Martin AJ, Qayyum A, et al. Parallel imaging and diffusion tensor imaging for diffusion-weighted MRI of the liver: preliminary experience in healthy volunteers. AJR Am J Roentgenol 2004; 183: 677-680.
107. Dietrich O, Biffar A, Baur-Melnyk A, Reiser MF,. Technical aspects of MR diffusion imaging of the body. Eur J Radiol 2010; 76: 314-322.
108. Willinek WA, Gieseke J, Kukuk GM, et al. Dual-source parallel radiofrequency excitation body MR imaging compared with standard MR imaging at 3.0 T: initial clinical experience. Radiology 2010; 256: 966-975.
109. Sasaki M, Yamada K, Watanabe Y, et al. Variability in absolute apparent diffusion coefficient values across different platforms may be substantial: a multivendor, multi-institutional comparison study. Radiology 2008; 249: 624-630.
110. Dale BM, Braithwaite AC, Boll DT, Merkle EM,. Field strength and diffusion encoding technique affect the apparent diffusion coefficient measurements in diffusion-weighted imaging of the abdomen. Invest Radiol 2010; 45: 104-108.
111. Koh DM, Blackledge M, Collins DJ, et al. Reproducibility and changes in the apparent diffusion coefficients of solid tumours treated with combretastatin A4 phosphate and bevacizumab in a two-centre phase I clinical trial. Eur Radiol 2009; 19: 2728-2738.
112. Kyriazi S, Blackledge M, Collins DJ, deSouza NM,. Optimising diffusion-weighted imaging in the abdomen and pelvis: comparison of image quality between monopolar and bipolar single-shot spin-echo echo-planar sequences. Eur Radiol 2010; 20: 2422-2431.
113. Alexander AL, Tsuruda JS, Parker DL,. Elimination of eddy current artifacts in diffusion-weighted echo-planar images: the use of bipolar gradients. Magn Reson Med 1997; 38: 1016-1021.
114. Deng J, Omary RA, Larson AC,. Multishot diffusion-weighted SPLICE PROPELLER MRI of the abdomen. Magn Reson Med 2008; 59: 947-953.
115. Hirokawa Y, Isoda H, Okada T, et al. Improved detection of hepatic metastases from pancreatic cancer using periodically rotated overlapping parallel lines with enhanced reconstruction (PROPELLER) technique after SPIO administration. Invest Radiol 2010; 45: 158-164.
116. Ivancevic MK, Kwee TC, Takahara T, et al. Diffusion-weighted MR imaging of the liver at 3.0 Tesla using TRacking Only Navigator echo (TRON): a feasibility study. J Magn Reson Imaging 2009; 30: 1027-1033.
117. Takahara T, Kwee TC, Van Leeuwen MS, et al. Diffusion-weighted magnetic resonance imaging of the liver using tracking only navigator echo: feasibility study. Invest Radiol 2010; 45: 57-63.
118. Padhani AR, Liu G, Koh DM, et al. Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia 2009; 11: 102-125.
119. Koh DM, Collins DJ, Orton MR,. Intravoxel incoherent motion in body diffusion-weighted MRI: reality and challenges. AJR Am J Roentgenol 2011; 196: 1351-1361.